EP2875011
5-HT3 viðtakamótlyf
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.7.2013EP published:
10.1.2018EP application number:
13742355.4
EP translation filed:
26.3.2018Grant published:
15.4.2018EPO information:
European Patent Register
Max expiry date:
15.7.2033Expiry date:
15.7.2026Next due date:
31.7.2026
Title:
5-HT3 RECEPTOR ANTAGONISTS
Timeline
Today
16.7.2013EP application
10.1.2018EP Publication
26.3.2018Translation submitted
15.4.2018Registration published
15.7.2026Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi-4-chome, Chuo-ku, Osaka-shi,, 541-0045, Osaka, JP
Inventor
Name:
HITCHCOCK, StephenAddress:
San Diego, California, US
Name:
MONENSCHEIN, HolgerAddress:
San Diego, California, US
Name:
REICHARD, HollyAddress:
San Diego, California, US
Name:
SUN, HuikaiAddress:
San Diego, California, US
Name:
KIKUCHI, ShotaAddress:
San Diego, California, US
Name:
MACKLIN, ToddAddress:
San Diego, California, US
Name:
HOPKINS, MariaAddress:
San Diego, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261672709 PDate:
17.7.2012Country:
US
Number:
201261708521 PDate:
1.10.2012Country:
US
Classification
Categories:
C07D 221/22, C07D 471/04, C07D 453/02, C07D 471/08, C07C 53/18, A61K 31/19, A61K 31/5386, C07D 451/12, C07D 498/08, C07D 519/00, C07C 53/40
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 2.7.2018
Expires: 15.7.2019
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 2.7.2019
Expires: 15.7.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 1.7.2020
Expires: 15.7.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 1.7.2021
Expires: 15.7.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 19.10.2022
Expires: 15.7.2023
Payer: Patice ehf.
Number: 11
Paid: 22.6.2023
Expires: 15.7.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 19.6.2024
Expires: 15.7.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.7.2025
Expires: 15.7.2026
Payer: Árnason Faktor ehf.